NASDAQ:CARA
Cara Therapeutics Stock News
$0.716
-0.0445 (-5.85%)
At Close: May 10, 2024
Cannabis Central's Pot Stock Index Was Unchanged Monday But Aurora Was Down 10.3%
12:00am, Monday, 11'th May 2020The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Cara Therapeutics to Present at the Virtual BofA Securities 2020 Health Care Conference
11:00am, Thursday, 07'th May 2020
STAMFORD, Conn., May 07, 2020 -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to.
Pot Stock Index Up 0.6% Tuesday: Here Are The Biggest Winners & Losers
12:00am, Tuesday, 05'th May 2020Cara Therapeutics to Announce First Quarter 2020 Financial Results on May 11, 2020
09:01pm, Monday, 04'th May 2020
STAMFORD, May 04, 2020 (GLOBE NEWSWIRE via COMTEX) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and...
Cara Therapeutics to Announce First Quarter 2020 Financial Results on May 11, 2020
08:01pm, Monday, 04'th May 2020
STAMFORD, Conn., May 04, 2020 -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to.
Cannabis Central: Pot Stock Sector Up 1.7% On Monday; NPSI Up 3.0%
12:00am, Monday, 04'th May 2020Cannabis Central: All But Two NPSI Constituents Declined On Friday
10:26pm, Saturday, 02'nd May 2020
The index tracking the 35 cannabis stocks that trade for US$1/share or more (i.e. 12% of the universe of 298 companies) was down 3.9% on Friday.
We Think Cara Therapeutics (NASDAQ:CARA) Needs To Drive Business Growth Carefully
12:35pm, Saturday, 02'nd May 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Cara Therapeutics Inc (NASDAQ:CARA) Expected to Announce Quarterly Sales of $4.83 Million
09:46am, Friday, 01'st May 2020
Brokerages expect Cara Therapeutics Inc (NASDAQ:CARA) to report sales of $4.83 million for the current fiscal quarter, Zacks reports. Five analysts have made estimates for Cara Therapeutics’ earning
Better Buy: Cara Therapeutics vs. Sangamo Therapeutics
11:14am, Wednesday, 29'th Apr 2020
Take Cara Therapeutics (NASDAQ: CARA) and Sangamo Therapeutics (NASDAQ: SGMO), for example. One thing that both Cara and Sangamo have in common, though, are promising pipeline candidates. Investor
Will Cara Therapeutics (NASDAQ:CARA) Spend Its Cash Wisely?
11:03am, Wednesday, 29'th Apr 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Cara Therapeutics (NASDAQ:CARA) Rating Lowered to Hold at Zacks Investment Research
10:10am, Wednesday, 29'th Apr 2020
Cara Therapeutics (NASDAQ:CARA) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Monday, Zacks.com rep
Zacks: Analysts Anticipate Cara Therapeutics Inc (NASDAQ:CARA) Will Announce Earnings of -$0.63 Per Share
08:00am, Wednesday, 29'th Apr 2020
Equities analysts expect Cara Therapeutics Inc (NASDAQ:CARA) to report earnings per share (EPS) of ($0.63) for the current quarter, Zacks reports. Five analysts have made estimates for Cara Therapeuti
